Benzodiazepine Abuse: Nature and Extent of the Problem

CNS Drugs

Volumn 5, Issue 2, 1996, Pages 137-146

  Robertson, J Roy ^a   Treasure, Wilfrid ^b  

^a Edinburgh Drug Addiction Study   (United Kingdom)

^b Muirhouse Medical Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ATAXIA; CONFUSION; DROWSINESS; DRUG ABUSE; DRUG WITHDRAWAL; FATIGUE; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT; VERTIGO;

EID: 0030046728     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199605020-00005     Document Type: Article

References (59)

1. Plant M. What aetiologies? In: Edwards G, Busch C, editors. Drug problems in Britain. A review of ten years. London: Academic Press, 1981: 245-80
2. Turner D. The development of the voluntary sector: no further need for pioneers? In: Strang J, Gossop M. Heroin addiction and drug policy. The British system. Oxford: Oxford Medical Publications, 1994: 223-4
3. The La Roche affair. In: Gossop M. Living with drugs. London: Ashgate, 1993: 53-5
4. Clare AW. Diazepam, alcohol and barbiturate abuse. BMJ 1971; 4: 340
5. Hanna SM. A case of oxazepam (Serenid D) dependence. Br J Psychiatry 1972; 120: 443-5
6. Misra PC. Nitrazepam (Mogadon) dependence. Br J Psychiatry 1975; 126: 81-2
7. Benzodiazepines: use, overuse, misuse, abuse. Lancet 1973 May 19; 1: 1101-2
8. Department of Health and Social Security Advisory Council on the Misuse of Drugs. Treatment and rehabilitation. London: HMSO, 1982
9. Department of Health. Drug misuse and drug dependence: guidelines on clinical management. London: HMSO, 1991
10. Scottish Office Home and Health Department and Scottish Health Services Advisory Council. The management of anxiety and insomnia. A report by the National Medical Advisory Service. Edinburgh: HMSO, 1994
11. Klee H, Fauzier J, Hayes C, et al. Aids-related risk behaviour, polydrug use and temazepam. Br J Addict 1990; 85: 1125-32
12. Ruben SM, Morrison CL. Temazepam misuse in a group of injecting drug users. Br J Addict 1992: 87; 1387-92
13. Bond A, Seijas D, Dawling S, et al. Systemic absorption and abuse liability of snorted flunitrazepam. Addiction 1994; 89: 821-30
14. Leitner M, Shapland J, Wiles P. Drug usage and drugs prevention: the views and habits of the general public. UK: Home Office (HMSO), 1993
15. King MB. Long-term benzodiazepine users - a mixed bag. Addiction 1994; 89: 1367-70
16. McInnes E, Powell J. Drug and alcohol referrals: are elderly substance abuse diagnoses and referrals being missed? BMJ 1994; 308: 444-6
17. Wright N, Caplan R, Payne S. Community survey of long term daytime use of benzodiazepines. BMJ 1994; 309: 27-8
18. Wright JD, Pearl L. Knowledge and experience of young people regarding drug misuse, 1969-94. BMJ 1995; 310: 20-4
19. Robertson JR, Ronald PJM, Raab GM, et al. Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years. BMJ 1994; 309: 369-72
20. Ross HE. Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction 1993; 88: 209-18
21. McDermott P. McDermott's guide to the depressant drugs. Manchester: Lifeline Publications, 1993
22. Darke S. Benzodiazepine use among injecting drug users: problems and implications. Addiction 1994; 89: 379-82
23. Darke S, Ross J, Cohen J. The use of benzodiazepines among regular amphetamine users. Addiction 1994; 89: 1683-90
24. Darke S, Hall W, Ross M, et al. Benzodiazepine use and HIV risk-taking behaviour among injecting drug users. Drug Alcohol Depend 1992; 31: 31-6
25. Gutierrez-Cebollada J, de la Torre R, Ortuno J, et al. Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend 1994; 35: 169-74
26. Robertson JR. Benzodiazepine super-abuse [letter]. Br J Gen Pract 1994; 44 (383): 282
27. Golombok S. Causes, effects and treatment of long-term benzodiazepine use: a review of psychological perspectives. Hum Psychopharm 1989; 4: 15-22
28. Griffith RR, Bigelow GE, Liebson E. Differential effects of diazepam and pentobarbital on mood and behaviour. Arch Gen Psychiatry 1983; 40: 865-73
29. Strang J, Seivewright N, Farrell M. Intravenous and other novel abuses of benzodiazepines: the opening of Pandora's box? Br J Addict 1992; 87: 1373-5
30. Navaratnam V, Foong K. Opiate dependence - the role of benzodiazepines. Curr Med Res Opin 1990; 11 (10): 620-30
31. Lader M. Benzodiazepines in profile. Prescr J 1989; 29 (1): 12-7
32. King MB. Is there still a role for benzodiazepines in general practice? Br J Gen Pract 1992; 42: 202-5
33. Hudson MMT, Edmonds M, Watkins PJ. Misuse of temazepam [letter]. BMJ 1991; 303: 993
34. Maany I, Greenfield H, Dhopesh V, et al. Urinary retention as a possible complication of long-term diazepam abuse. Am J Psychiatry 148; 5: 685
35. Bergman U, Rosa FW, Baum C. Effects of exposure to benzodiazepine during fetal life. Lancet 1992; 340: 694-6
36. Crofts N, Stewart T, Hearne P, et al. Spread of bloodborne viruses among Australian prison entrants. BMJ 1995; 310: 285-8
37. Advisory Council on the Misuse of Drugs. Aids and drug misuse report. London: HMSO, 1989
38. Petursson H. The benzodiazepine withdrawal syndrome. Addiction 1994; 89: 1455-9
39. Brenner PM, Wolf B, Rechlin T, et al. Benzodiazepine dependence: detoxification under standardized conditions. Drug Alcohol Depend 1991; 29: 195-204
40. Brahams D. Medicine and the law. Lancet 1990; 336: 1372-3
41. Strang J, Griffiths P, Abbey J, et al. Survey of use of injected benzodiazepines among drug users in Britain. BMJ 1994; 308: 1082
42. Des Jarlais DC. Harm reduction - a framework for incorporating science into drug policy. Am J Public Health 1995; 85 (1): 10-1
43. Ronald PJM, Robertson JR, Wyld R, et al. Heterosexual transmission of HIV in injecting drug users. BMJ 1993; 307: 1184-5
44. Hall AJ. Hepatitis B vaccination: protection for how long and against what? Booster injections are not indicated. BMJ 1993; 307: 276-7
45. Hindler C, Nazareth I, King M, et al. Drug users' views on general practitioners. BMJ 1995; 310: 302
46. Robertson JR. Treatment for drug dependence [letter]. Lancet 1994; 344: 1640
47. Tantam D, Donmall M, Webster A, et al. Do general practitioners and general psychiatrists want to look after drug misusers? Evaluation of a non-specialist treatment policy. Br J Gen Pract 1993; 43: 470-4
48. Gill ON, Noone A, Heptonstall J. Imprisonment, injecting drug use, and bloodborne viruses: a threat of transmission but an opportunity for prevention. BMJ 1995; 310: 275-6
49. Christie B. Prison policies put inmates at risk. BMJ 1995; 310: 279
50. Seivewright N. Benzodiazepine use among injecting drug users [letter]. Addiction 1994; 89: 1701-3
51. Barnas C, Rossmann M, Roessler H, et al. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. J Clin Psychopharmacol 1992; 12: 397-402
52. Darke SG, Ross JK, Hall WD. Benzodiazepine use among injecting heroin users. Med J Aust 1995; 162: 645-7
53. Griffiths RR, Wolf B. Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol 1990: 10: 237-43
54. Gabe J. Promoting benzodiazepine withdrawal. Addiction 1994; 89: 1497-504
55. Ashton H. The treatment of benzodiazepine dependence. Addiction 1994; 89: 1535-41
56. Darke S. Benzodiazepine use among injecting drug users: reply to Dr. Seivewright [letter]. Addiction 1994; 89: 1703
57. Lader M. Biological processes in benzodiazepine dependence. Addiction 1994; 89: 1413-8
58. Farrell M, Strang J, Needleman J, et al. Policy on drug misuse in Europe. BMJ 1994; 308: 609-10
59. New body to fight drugs [news item]. Lancet 1994; 343: 1220